chemXplore tracks 60 projects in Mexico, of which 43 are active.
Of the active ones, 18 new construction, 18 expansion and 7 revamp / retrofit.
27 active projects carry no start-up date yet. The dates themselves, per project, are for subscribers.
Once‑daily oral GLP‑1 cut MACE vs insulin glargine, lowered A1C by 1.6% at 52 weeks and produced mean weight loss of 8.1 kg with durable effects to 104 weeks.
EU launches anti-dumping probe after PVC imports doubled in 12 months; industry urges faster provisional measures, safeguards and more DG Trade resources to protect European production.
An indirect, covariate‑adjusted comparison of SURMOUNT‑1 and STEP UP data shows larger mean and categorical weight‑loss benefits with tirzepatide 10 mg and 15 mg at 72 weeks.
FDA clears once‑weekly basal insulin that reduces injection frequency vs daily therapy; Phase 3 QWINT trials in >3,400 adults showed non‑inferior A1C vs glargine and degludec.
Cryoinfra 50,000 Nm³/h air separation cold box and atmospheric storage tank installation in Mexico reaches intermediate handover.
LR1-class naphtha carrier (89,500 m³) with ~30% CO₂ reduction; four-vessel series to cover 40–50% of naphtha imports; Bold Future due Jan 2027.
Exclusive distribution expands Mexican personal-care lineup with nature-derived ingredients for skin, hair, color and oral formulations, plus improved supply reliability and formulation support.
Revenue rose 9% to $4.3B; new awards $6.1B and backlog $26.9B; adjusted EBITDA guidance narrowed and reduced; $300M returned to shareholders in Q2.
Presents >4% sales CAGR and 4–5% adjusted EBITDA margin targets, details growth strategy and plans a minority-stake spin-off subject to thyssenkrupp shareholder vote on 7 Aug 2026.
16.6% stakeholder will offtake 1.7 Mtpa for 20 years and be sole offtaker during ramp-up; Phase 1 is 3.25 Mtpa using Permian feed gas; completion expected summer 2026.
active / all projects
The 10 with the most active projects, of 13 parks.
